Regentis Biomaterials Ltd Net Income per Employee (RGNT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Regentis Biomaterials Ltd   (RGNT)
 

Regentis Biomaterials Ltd Net Income per Employee

RGNT's Quarterly Results, Trends, Rankings, Statistics
Regentis Biomaterials Ltd recorded a cumulative net loss of $-14 million during 12 month ending in the fourth quarter 2025.
The Healthcare sector has seen employees of 202 other companies achieving higher income per employee. While Regentis Biomaterials Ltd 's total ranking has deteriorated compared to the previous quarter from to 4481.


What is Income per Employee Ratio?






RGNT Net Income per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Sep 30 2017)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,706,000 -1,517 -5,702 -9,928 -11,146
RGNT's Total Ranking # 4481 # # # #
Seq. Net Income Change - - - - -


RGNT Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 203
Healthcare Sector # 833
Overall Market # 4481

Net Income per Employee Statistics
High Average Low
$ 12,609 $ -427,246 $ -1,706,000
(Dec 31 2013)   (Dec 31 2025)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025


Date modified: 2026-07-07T13:05:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.